Product
Phase 2
1 clinical trial
1 indication
Indication
SpasticityClinical trial
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb SpasticityStatus: Active (not recruiting), Estimated PCD: 2023-04-01